Biodetectors And Accessories Market size is projected to observe notable traction from 2023 to 2032 due to the escalating pollution levels and increasing burden of airborne diseases.
The intensifying awareness about environmental degradation has given way to favorable government initiatives and awareness campaigns, generating multiple market opportunities. The higher threat of cardiovascular diseases, arsenicosis, cancers, and chronic kidney ailments will also enhance the industry outlook. For instance, according to the Centers for Disease Control and Prevention, about 37 million American individuals have chronic kidney disease (CKD), with the majority going untreated.
However, the inadequate awareness in under-developed economies and higher costs of procuring the bio detector systems might hinder the industry progression to some extent. Furthermore, the Russia-Ukraine war has led raw material costs to skyrocket in recent years. Several companies, including those in the biodetectors and accessories market, faced challenges due to a lack of crucial components, significant increases in shipping costs, and erratic supply schedules. This trend is anticipated to continue over the next few years, since growing inflation could hinder industrial expansion.
In terms of application, the demand for biodetectors and accessories in clinical use will rise through 2023-2032 with the thriving need for detecting biomarkers, toxins, illicit drugs, and pathogens. The growing focus of medical practitioners on safe and cheaper ways of performing their research, while ensuring public safety, and offering customized health options to patients is another prominent trend impacting the biodetectors and accessories industry gains. Significant strides in biomedical studies of diagnosis and increasing number of DNA analysis which will further augment the product penetration.
With regards to end-use, the point of care testing segment will bring significant revenue share for the biodetectors and accessories marketowing to increasing penetration in rapid medical diagnosis and drug toxicology studies. The use of biodetectors and accessories in point-of-care testing helps in quick detection of analytes near to patients and better disease diagnosis, monitoring, and management.
North America is anticipated to witness higher consumption of biodetectors and accessories due to the increasing number of government initiatives for reinforcing counterterrorism and homeland security. The growing air pollution levels have made way for higher technological advancements and increased burden of various chronic diseases. Around 133 million Americans suffer one or more chronic diseases. Moreover, chronic illness accounts for 70% of all fatalities in the U.S.
Robust presence of key biodetectors and accessories market players along with the escalating healthcare expenditure has resulted in the surging number of R&D investments and product launches. The increasing threat of contact diseases, including Ebola, as well as growing government emphasis on enhancing biosecurity and higher availability of a well-developed infrastructure, will favor the development of bio-detectors and other critical medical devices.
Some of the key companies in global market comprise BBI Detection, Research International (WPP plc, Kantar Group), BioDetection Systems, Shimadzu, Smith Detection (Smiths Group), Bertin Technologies, MSA, PositiveID, Response BioMedical, Thermo Fisher Scientific, LightDeck Diagnostics (MBio Diagnostics), Bio Rad Laboratories, and Agilent Technologies.